Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $274.62 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $150.01 | 3 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $37.39 | 2 | $0 (2024) |
| Allergan, Inc. | $27.82 | 2 | $0 (2022) |
| GENZYME CORPORATION | $24.89 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $17.36 | 1 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $17.15 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $152.28 | 3 | Bausch & Lomb Americas Inc. ($131.52) |
| 2023 | $35.12 | 2 | Bausch & Lomb Americas Inc. ($18.49) |
| 2022 | $15.78 | 1 | Allergan, Inc. ($15.78) |
| 2019 | $24.89 | 1 | GENZYME CORPORATION ($24.89) |
| 2018 | $17.15 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($17.15) |
| 2017 | $29.40 | 2 | Valeant Pharmaceuticals North America LLC ($17.36) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | Bausch & Lomb Americas Inc. | DOCTORS ALLERGY FORMULA (Device) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Ophthalmology | ||||||
| 02/16/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.05 | General |
| Category: Ophthalmology | ||||||
| 01/11/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/20/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Ophthalmology | ||||||
| 01/20/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/19/2019 | GENZYME CORPORATION | FABRY-DISEASE (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| 03/06/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), ZYLET, VYZULTA | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/09/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: DRY EYE | ||||||
| 06/08/2017 | Valeant Pharmaceuticals North America LLC | BESIVANCE (Drug), TIMOPTIC OCUDOSE, ISTALOL | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,060 | 1,189 | $167,085 | $68,366 |
| 2022 | 8 | 1,175 | 1,348 | $192,355 | $70,101 |
| 2021 | 7 | 1,207 | 1,520 | $212,795 | $80,939 |
| 2020 | 9 | 1,253 | 1,497 | $230,629 | $80,647 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 244 | $36,600 | $25,551 | 69.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 261 | 267 | $46,725 | $20,340 | 43.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 182 | 187 | $25,840 | $8,603 | 33.3% |
| 92250 | Photography of the retina | Office | 2023 | 227 | 287 | $36,200 | $7,908 | 21.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 163 | 164 | $16,400 | $3,882 | 23.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 12 | 12 | $2,520 | $1,297 | 51.5% |
| 92134 | Imaging of retina | Office | 2023 | 28 | 28 | $2,800 | $785.59 | 28.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 268 | 272 | $47,600 | $18,401 | 38.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 183 | 241 | $27,715 | $17,147 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 95 | $14,250 | $9,883 | 69.4% |
| 92250 | Photography of the retina | Office | 2022 | 236 | 336 | $50,400 | $8,595 | 17.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 181 | 186 | $26,040 | $8,324 | 32.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 169 | 172 | $17,200 | $4,215 | 24.5% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 11 | 13 | $5,850 | $2,648 | 45.3% |
| 92134 | Imaging of retina | Office | 2022 | 32 | 33 | $3,300 | $888.83 | 26.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 229 | 415 | $47,725 | $30,060 | 63.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 271 | 280 | $49,000 | $19,946 | 40.7% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 204 | 208 | $29,120 | $10,240 | 35.2% |
| 92250 | Photography of the retina | Office | 2021 | 245 | 352 | $52,750 | $10,225 | 19.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 205 | 205 | $20,500 | $5,316 | 25.9% |
| 65855 | Laser repair to improve eye fluid flow, 1 or more sessions | Office | 2021 | 16 | 22 | $9,900 | $4,034 | 40.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 37 | 38 | $3,800 | $1,118 | 29.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 203 | 347 | $40,025 | $24,721 | 61.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 306 | 309 | $49,955 | $20,723 | 41.5% |
| 92250 | Photography of the retina | Office | 2020 | 274 | 356 | $58,750 | $11,317 | 19.3% |
About Dr. Mark Rubinstein, MD
Dr. Mark Rubinstein, MD is a Ophthalmology healthcare provider based in Ft Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952392292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Rubinstein, MD has received a total of $274.62 in payments from pharmaceutical and medical device companies, with $152.28 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($274.62).
As a Medicare-enrolled provider, Rubinstein has provided services to 4,695 Medicare beneficiaries, totaling 5,554 services with total Medicare billing of $300,053. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Ft Lauderdale, FL
- Active Since 11/04/2005
- Last Updated 01/11/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1952392292
Products in Payments
- MIEBO (Drug) $125.05
- LIVALO (Drug) $37.39
- BESIVANCE (Drug) $34.51
- FABRY-DISEASE (Drug) $24.89
- INFUSE (Device) $18.49
- VUITY (Drug) $15.78
- RESTASIS (Drug) $12.04
- DOCTORS ALLERGY FORMULA (Device) $6.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Ft Lauderdale
Sunir Joshi, M.d, M.D
Ophthalmology — Payments: $924,809
Dr. Eduardo Uchiyama, M.d, M.D
Ophthalmology — Payments: $361,047
Dr. Robert Kramm, Md, Mse, MD, MSE
Ophthalmology — Payments: $128,093
Dr. Mario Del Cid, Md, MD
Ophthalmology — Payments: $14,565
Barry Taney, Md, MD
Ophthalmology — Payments: $11,060
Lawrence Halperin, Md, MD
Ophthalmology — Payments: $10,765